Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Compound Staphylococcal Lysostaphin Versus Chlorhexidine Mouthrinse for the Prophylaxis of Oral Mucositis in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: a Randomized, Controlled, Non-inferiority Clinical Tria

NCT06791746 is registered in ClinicalTrials.gov with Zhejiang University as lead sponsor.

NCT NCT06791746
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06791746 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Compound Staphylococcal Lysostaphin Versus Chlorhexidine Mouthrinse for the Prophylaxis of Oral Mucositis in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: a Randomized, Controlled, Non-inferiority Clinical Tria
Lead sponsor
Zhejiang University
Phase
Phase 3
Overall status
Completed
Start date
January 2, 2020
Completion date
June 30, 2022
Enrollment
388 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

oral mucositis, stem cell transplant complications